Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

Obesity is a global pandemic. According to the World Health Organization (WHO), adult obesity in the world more than doubled ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

Diabetes is a long-term condition where too much sugar stays in the blood. If not managed well, it can get worse over time, ...

Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been ...

More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health ...

A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...

Andy Richter said he looked into taking weight-loss drugs despite not having type 2 diabetes. However, his insurance company ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...